© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Liz is Science Editor for Cancer Health, POZ, Hep and Real Health. She has been a health journalist and medical editor for more than 20 years, covering HIV, viral hepatitis, cancer and other health issues.
Although people over 60 are at greatest risk, younger people can develop serious complications from the new coronavirus too.
Screening mammograms should be postponed until later this year—or longer, if the coronavirus crisis continues.
Drugs used for decades to treat malaria may help people with the new coronavirus, but clinical trials are needed.
The protease inhibitor combination did not work significantly better than supportive care, though those treated earlier might benefit.
Plus: tips for caring for your furry friends during the health crisis.
The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.
What’s the best time to start these important cancer screenings?
Our spring issue is devoted to the theme of treatment.
Customized treatments demonstrate good response rates for mantle cell lymphoma and chronic lymphocytic leukemia.
Last year, the FDA approved three new antibody-drug conjugates for treating cancer.
Tucatinib fights breast cancer that spreads to the brain
Preliminary research suggests that such rapid dosing of radiation could one day become a reality for cancer treatment.
New research shows that treating these viruses can reduce liver cancer risk.
Available vaccines offer protection against cervical, anal, oral, liver and stomach cancers.
We’re all familiar with vaccines that prime the immune system to prevent infections. Can a similar approach be used to fight cancer?
Immune modulator demonstrated an overall response rate of 52%
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
